Bruker (BRKR) FY2025 results: revenue $3.4 billion, up 2.1% on the year

Bruker develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions that let customers study life and materials at microscopic, molecular and cellular levels. Many of its products detect, measure and visualize the structure of chemical, biological and industrial samples. Its customers work in life and materials science research, biopharmaceuticals, applied markets, microbiology, in-vitro diagnostics and nanotechnology. It reports four segments: BSI BioSpin, BSI CALID, BSI NANO and Bruker Energy & Supercon Technologies, known as BEST.

BSI BioSpin: magnetic resonance and preclinical imaging

BioSpin makes nuclear magnetic resonance and electron paramagnetic resonance systems, ranging from benchtop to ultra-high field. In NMR, a molecule placed in a magnetic field gives off a radio frequency that identifies it and reveals its structure. The segment also makes preclinical imaging systems using MRI, PET, SPECT, CT and magnetic particle imaging, used on animals in drug discovery and in fields such as oncology, neurology and cardiology, plus lab automation and data software. The majority of BioSpin customers are academic and government research facilities. In 2025 the segment completed two additional installations of 1.2 GHz NMR systems.

BSI CALID: mass spectrometry and diagnostics

CALID stands for chemicals, applied markets, life science, in vitro diagnostics and detection. Its life science mass spectrometry instruments, which measure the mass of molecules, are used in research and in pharmaceutical and biotechnology development. Applied mass spectrometry serves food, environmental, forensics, clinical research and industrial markets, in areas such as toxicology, authenticity and adulteration testing. The microbiology and infection diagnostics division makes products for microbial identification, antibiotic resistance and susceptibility testing, and PCR based molecular diagnostics for culture-free infectious disease testing.

BSI NANO: X-rays, electron microscope tools and surfaces

Bruker AXS makes X-ray instruments that determine the characteristics of matter and the three-dimensional structure of molecules, based on techniques including X-ray fluorescence, X-ray diffraction and X-ray micro computed tomography. The segment also makes analytical tools for electron microscopes, and atomic force microscopy instruments that resolve surface topography at or near atomic resolution.

BEST: superconductors

BEST makes superconducting materials, both low temperature and high temperature superconductors, for use in MRI, NMR, fusion energy research and high-energy physics. Its products include multifilament round and rectangular low temperature superconductor wires. It also makes Cuponal, a copper-clad aluminum used as an alternative to solid copper wire and busbar, primarily in the aerospace industry, and sells synchrotron and beamline instrumentation. BEST has a joint technology development agreement with Allegheny Technologies to advance niobium-based superconductors, including those used in MRI magnets.

How it makes and sells

Facilities in Europe, Israel and California carry out all phases of manufacturing, from machining and fabrication to system assembly and final testing, while other sites mainly do high-level assembly, integration and testing. The company typically makes critical components in-house and outsources non-critical ones. It has direct sales forces throughout North America, Europe, China, Japan and elsewhere in Asia Pacific, and uses distributors and independent representatives in parts of Asia, Latin America, Africa, the Middle East and Eastern Europe. The sales cycle is typically three to twenty-four months for academic and high-end research products and two weeks to six months for industrial products. Sales have historically been higher in the fourth quarter and lower in the first, which the company attributes to customers' budgeting cycles.

People

As of December 31, 2025 Bruker had approximately 11,085 employees worldwide, approximately 20.2% of them in the United States. About 45.8% worked in production and distribution, 23.5% in selling and marketing and 17.6% in research and development.

From Bruker's annual report on Form 10-K for the year ended 31 December 2025. The filing

Written from the 10-K filed 27 February 2026: read the full 10-K.